中国保健营养（上旬刊）
中國保健營養（上旬刊）
중국보건영양（상순간）
China Health Care & Nutrition
2014年
4期
1934-1934,1935
,共2页
胆汁反流性胃炎%幽门螺杆菌%左氧氟沙星+阿莫西林+莫沙必利+奥美拉唑四联疗法
膽汁反流性胃炎%幽門螺桿菌%左氧氟沙星+阿莫西林+莫沙必利+奧美拉唑四聯療法
담즙반류성위염%유문라간균%좌양불사성+아막서림+막사필리+오미랍서사련요법
Bile Reflux Gastritis%Helicobacter Pylori
目的：探讨幽门螺杆菌（HP）阳性的原发性胆汁反流性胃炎的临床治疗方法。方法将90例HP阳性原发性胆汁反流性胃炎患者随机分为试验组和对照组各45例，试验组予以莫沙必利＋奥美拉唑＋左氧氟沙星＋阿莫西林四联疗法，对照组予以莫沙必利＋奥美拉唑两联治疗，观察并比较2组的临床疗效及HP根除率。结果试验组临床有效率为85％，HP根除率为82％，远远高于对照组的63％、10％，有统计学意义（P＜0．05）。结论对于合并HP感染的原发性胆汁反流性胃炎，左氧氟沙星＋阿莫西林＋莫沙必利＋奥美拉唑四联疗法能取得满意的临床疗效及提高HP根除率。
目的：探討幽門螺桿菌（HP）暘性的原髮性膽汁反流性胃炎的臨床治療方法。方法將90例HP暘性原髮性膽汁反流性胃炎患者隨機分為試驗組和對照組各45例，試驗組予以莫沙必利＋奧美拉唑＋左氧氟沙星＋阿莫西林四聯療法，對照組予以莫沙必利＋奧美拉唑兩聯治療，觀察併比較2組的臨床療效及HP根除率。結果試驗組臨床有效率為85％，HP根除率為82％，遠遠高于對照組的63％、10％，有統計學意義（P＜0．05）。結論對于閤併HP感染的原髮性膽汁反流性胃炎，左氧氟沙星＋阿莫西林＋莫沙必利＋奧美拉唑四聯療法能取得滿意的臨床療效及提高HP根除率。
목적：탐토유문라간균（HP）양성적원발성담즙반류성위염적림상치료방법。방법장90례HP양성원발성담즙반류성위염환자수궤분위시험조화대조조각45례，시험조여이막사필리＋오미랍서＋좌양불사성＋아막서림사련요법，대조조여이막사필리＋오미랍서량련치료，관찰병비교2조적림상료효급HP근제솔。결과시험조림상유효솔위85％，HP근제솔위82％，원원고우대조조적63％、10％，유통계학의의（P＜0．05）。결론대우합병HP감염적원발성담즙반류성위염，좌양불사성＋아막서림＋막사필리＋오미랍서사련요법능취득만의적림상료효급제고HP근제솔。
Objective To investigate the clinical treatment options of helicobacter pylori -positive patients with primary bile reflux gastritis .Methods 90 helicobact-er pylori-positive patients with primary bile reflux gastritis were randomized to the test group or the control group in 1:1 ratio,45 patients per group.The patients in the control group received mosapride plus omeprazole,and the patients in the test group,besides the two drugs described above,also received levofloxacin and amoxicillin. Observe and compare the efficacy and eradication rate between two groups.Results The overall clinical effective rate and eradication rate in the test group (85% and 82%,respectively)were statistically significantly higher than that of the control group(63% and 10%,respectively;P<0.05).Conclusion The helicobacter pylori erad-ication therapy is better for the helicobacter pylori -positive patients with primary bile reflux gastritis .
